Security Snapshot

Biohaven Ltd. - Common Shares (BHVN) Institutional Ownership

CUSIP: G1110E107

13F Institutional Holders and Ownership History from Q2 2022 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

226

Shares (Excl. Options)

101.43MFull value: 101,430,036 · shares · 30 Sep 2026

Price

$13.35

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-8,294,798
Value change
-$115,409,941
Number of holders
226
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
145,442,643
SEC-reported price per share
$16.49
Insider filing price
$16.49
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BHVN - Biohaven Ltd. - Common Shares is tracked under CUSIP G1110E107.
  • 226 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 295 to 226 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $2.1BFull value: $2,099,395,156 · USD · 30 Jun 2026
    to
    $1.35BFull value: $1,353,547,277 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 226 institutions filings for Q3 2026.

Open SEC evidence

Security key

G1110E107

13F reference period

Q3 2026

13F holders

226

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
BHVN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 7.8% $116,139,519 10,286,937 SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025
Woodline Partners LP 5.1% $120,726,013 7,660,280 Woodline Partners LP 30 Jun 2026
VANGUARD GROUP INC 2.7% $43,156,602 2,875,190 The Vanguard Group 30 Sep 2025
Janus Henderson Group Ltd. 1.4% -72% $27,183,230 -$87,422,195 2,036,197 -76% JANUS HENDERSON GROUP Ltd. 30 Sep 2026
As of 30 Sep 2026, 226 institutional investors reported holding
101.43MFull value: 101,430,036 · shares · 30 Sep 2026
shares of Biohaven Ltd. - Common Shares (BHVN). This represents 70% of the company’s total
145.44MFull value: 145,442,643 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
56%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MONTANOVA CAPITAL, LLC 7.1% 10,286,937 3.8% $137,330,609
STIFEL FINANCIAL CORP 6.8% 9,941,685 0.11% $132,721,494
Woodline Partners LP 5.3% 7,660,635 0.31% $102,269,477
STATE STREET CORP 4.7% 6,874,721 0% $91,777,525
INFINITUM ASSET MANAGEMENT, LLC 4.3% 6,250,000 7.2% $83,437,500
Rubric Capital Management LP 3.4% 4,875,000 0.61% $65,081,250
BANK OF AMERICA CORP /DE/ 2.8% 4,077,524 0% $54,434,947
GOLDMAN SACHS GROUP INC 2.6% 3,728,221 0.01% $49,771,750
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.2% 3,250,000 0.06% $43,387,500
Royalty Pharma Sub-Manager, LLC 2% 2,936,507 20% $39,202,368
GEODE CAPITAL MANAGEMENT, LLC 2% 2,891,378 0% $38,609,664
VANGUARD PORTFOLIO MANAGEMENT LLC 1.7% 2,502,667 0% $33,410,604
Janus Henderson Group Ltd. 1.4% 2,036,196 0.01% $27,182,871
Cormorant Asset Management, LP 1% 1,510,000 1.4% $20,158,500
VANGUARD CAPITAL MANAGEMENT LLC 0.96% 1,402,311 0% $18,720,852
ARS Investment Partners, LLC 0.94% 1,372,668 0.82% $18,325,118
ALGERT GLOBAL LLC 0.89% 1,291,773 0.21% $17,245,170
TCG Crossover Management, LLC 0.87% 1,262,423 0.48% $16,853,347
Capital Research Global Investors 0.82% 1,199,545 0% $16,013,926
Opaleye Management Inc. 0.82% 1,190,000 1.8% $15,886,500
Logos Global Management LP 0.76% 1,100,000 0.86% $14,685,000
Qube Research & Technologies Ltd 0.57% 833,568 0.01% $11,128,133
VANGUARD FIDUCIARY TRUST CO 0.55% 796,370 0% $10,631,540
Capricorn Fund Managers Ltd 0.53% 764,801 0.97% $10,210,093
5AM Venture Management, LLC 0.51% 738,972 3.3% $9,865,276

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
18
Headline period
Q3 2026
Rows shown
1-18 of 18
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 101,430,036 $1,353,547,277 -$115,409,941 $13.35 226
2026 Q2 141,118,507 $2,099,395,156 +$157,946,125 $14.88 295
2026 Q1 142,107,816 $1,202,636,638 +$180,823,041 $8.46 278
2025 Q4 121,437,146 $1,371,219,974 +$339,162,643 $11.29 271
2025 Q3 84,320,326 $1,263,904,622 -$38,241,337 $15.01 261
2025 Q2 86,987,421 $1,227,652,713 -$143,894,992 $14.11 247
2025 Q1 88,106,650 $2,142,495,070 -$115,214,537 $24.04 260
2024 Q4 89,346,784 $3,336,885,126 +$168,942,579 $37.35 253
2024 Q3 86,165,783 $4,306,353,110 +$148,383,281 $49.97 250
2024 Q2 82,422,187 $2,860,885,986 +$210,746,356 $34.71 222
2024 Q1 74,154,350 $4,055,673,624 +$161,363,053 $54.69 239
2023 Q4 71,802,540 $3,073,238,412 +$434,075,584 $42.80 214
2023 Q3 61,463,892 $1,598,669,852 +$39,755,212 $26.01 183
2023 Q2 60,120,418 $1,438,087,383 -$122,838,089 $23.92 183
2023 Q1 66,543,203 $909,962,550 +$54,642,668 $13.66 171
2022 Q4 62,449,262 $868,331,200 +$266,710,670 $13.88 168
2022 Q3 3,316,172 $499,083,000 +$491,524,000 $151.17 29
2022 Q2 $23.92 0
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .